SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $235,529 | +14.3% | 1,943 | +7.9% | 0.00% | 0.0% |
Q2 2023 | $206,135 | -4.4% | 1,800 | +15.1% | 0.00% | 0.0% |
Q1 2023 | $215,565 | +2.6% | 1,564 | -41.9% | 0.00% | +100.0% |
Q1 2022 | $210,000 | 0.0% | 2,693 | +15.5% | 0.00% | 0.0% |
Q4 2021 | $210,000 | -22.8% | 2,332 | -33.4% | 0.00% | -50.0% |
Q2 2021 | $272,000 | +11.9% | 3,499 | +7.4% | 0.00% | 0.0% |
Q1 2021 | $243,000 | -52.9% | 3,257 | +7.6% | 0.00% | -50.0% |
Q4 2020 | $516,000 | +15.2% | 3,027 | -5.1% | 0.00% | 0.0% |
Q3 2020 | $448,000 | -12.3% | 3,191 | +0.2% | 0.00% | -20.0% |
Q2 2020 | $511,000 | +61.7% | 3,184 | -1.5% | 0.01% | +25.0% |
Q1 2020 | $316,000 | – | 3,232 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |